Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kindly MD ( (NAKA) ) just unveiled an update.
Kindly MD, Inc. announced that its 2025 Annual Meeting of Stockholders will be held virtually on December 17, 2025, with October 23, 2025, set as the record date for stockholders entitled to vote. The meeting date has been moved forward by over 30 days from the previous year’s meeting, prompting a new deadline of October 6, 2025, for stockholder proposals and director nominations to be considered for inclusion in the proxy materials.
The most recent analyst rating on (NAKA) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
Spark’s Take on NAKA Stock
According to Spark, TipRanks’ AI Analyst, NAKA is a Underperform.
The overall stock score of 39 reflects significant financial challenges, bearish technical indicators, and poor valuation metrics. The company’s negative profitability and reliance on financing activities raise concerns about its financial health. The technical analysis indicates a bearish trend, and the lack of earnings call and corporate events data limits further insights.
To see Spark’s full report on NAKA stock, click here.
More about Kindly MD
Kindly MD, Inc., a Utah-based corporation, operates in the healthcare industry. The company, along with its subsidiary Nakamoto Holdings, Inc., focuses on providing medical products and services, leveraging various channels including websites, press releases, and social media for broad information dissemination.
Average Trading Volume: 8,280,088
Technical Sentiment Signal: Sell
For a thorough assessment of NAKA stock, go to TipRanks’ Stock Analysis page.